AWM
NAUT icon

Avior Wealth Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Avior Wealth Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,692
Closed -$23K – 1753
2024
Q4 		$23K Buy
13,692
+934
+7% +$2.23K ﹤0.01% 1378
2024
Q3 		$36.4K Hold
12,758
– – ﹤0.01% 1236
2024
Q2 		$29.9K Sell
12,758
-8,225
-39% -$21.5K ﹤0.01% 1258
2024
Q1 		$61.7K Buy
+20,983
New +$59.5K ﹤0.01% 1155

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Avior Wealth Management's NAUT Position: Q1 2025 in Review

Avior Wealth Management sold out of Nautilus Biotechnolgy (NAUT) in Q1 2025, closing a stake of 13,692 shares — an estimated $23K sold.

Avior Wealth Management first reported a position in NAUT in Q1 2024 and held it in 4 quarters. The position peaked at $61.7K in Q1 2024. 88 funds tracked by Wall St. Rank hold NAUT as of Q1 2025.

  • Avior Wealth Management reported no remaining Nautilus Biotechnolgy position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 13,692 Nautilus Biotechnolgy shares in Q1 2025, an estimated $23K.
  • Avior Wealth Management first reported a position in Nautilus Biotechnolgy in Q1 2024 and held it in 4 quarters.
  • Avior Wealth Management's Nautilus Biotechnolgy position peaked at $61.7K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.